Hypergammaglobulinemia is a strong predictor of disease progression, hepatocellular carcinoma, and death in patients with compensated cirrhosis.
Irene CacciolaRoberto FilomiaAngela AlibrandiMaria Stella FranzèGaia CaccamoSergio MaimoneCarlo SaittaFrancesca SaffiotiGiovanni SquadritoGiovanni RaimondoPublished in: Liver international : official journal of the International Association for the Study of the Liver (2018)
Hypergammaglobulinemia identifies C-P class A cirrhotic patients at higher risk of disease progression, HCC development and death.
Keyphrases